ArticlePharmacoEconomics2003

A stochastic economic evaluation of letrozole versus tamoxifen as a first-line hormonal therapy: for advanced breast cancer in postmenopausal patients.

Jon Karnon et al.PubMed ↗Publisher ↗

No numbers read from the abstract.